Clinical Vignette
Patient: "Mr. C," 33-year-old man with a 10-year history of Schizophrenia, referred by his outpatient psychiatrist for persistent functional impairment despite adequate control of positive symptoms on clozapine.
Chief Concern: Referring psychiatrist: "His hallucinations and delusions have been well controlled for 2 years on clozapine. But he sits in his apartment all day, barely speaks, doesn't shower unless reminded, and has no interest in anything. His mother thinks he's depressed, but he denies feeling sad."
History of Present Illness: Mr. C was diagnosed with Schizophrenia at age 23 following a first psychotic episode involving persecutory delusions and command auditory hallucinations. After trials of multiple antipsychotics, clozapine was initiated at age 28 and has effectively controlled his positive symptoms: no hallucinations or delusions for 2 years. Despite this, Mr. C demonstrates profound functional impairment. He spends 12-14 hours daily sitting in a chair watching television passively. He initiates no activities, avoids all social contact (has not left his apartment voluntarily in 3 months), speaks only when directly asked questions (responses are 1-3 word replies), shows no emotional response to any stimuli (flat affect), and reports no interest in any activities. He bathes and changes clothes only when his mother visits and instructs him. He denies feeling sad, hopeless, or suicidal. His appetite is adequate. Sleep is unremarkable.
Medical History: Schizophrenia (diagnosed age 23). Current medications: clozapine 400mg daily, benztropine 1mg twice daily. No metabolic comorbidities documented.
Mental Status Exam: Appears older than stated age. Hygiene fair (mother visited yesterday). Psychomotor retardation. Speech: markedly reduced spontaneous output; responses are monosyllabic. Mood 'okay.' Affect flat, no emotional variation throughout 45-minute interview. Thought process impoverished but linear. No hallucinations, no delusions. No suicidal or homicidal ideation. Insight limited. Judgment impaired by avolition.
Step 1: Identifying and Characterizing Negative Symptoms
DSM-5-TR identifies five primary negative symptoms of Schizophrenia. These are assessed independently of positive symptom status:
Avolition (diminished motivation to initiate and sustain purposeful activities)
Mr. C initiates no activities. Spends 12-14 hours passively watching television. Has not voluntarily left his apartment in 3 months. Requires external prompting for basic self-care. PRESENT — SEVERE.
Alogia (diminished speech output)
Speaks only when directly questioned. Responses limited to 1-3 words. No spontaneous speech initiated during 45-minute interview. PRESENT — SEVERE.
Anhedonia (diminished ability to experience pleasure)
Reports no interest in any activities. When asked what he enjoys, responds 'nothing really.' No behavioral evidence of pleasure-seeking. PRESENT — SEVERE.
Flat affect (diminished emotional expression)
No variation in facial expression, voice tone, or body language throughout the interview. Does not respond emotionally to humor, discussion of family, or discussion of losses. PRESENT — SEVERE.
Asociality (apparent lack of interest in social interactions)
Avoids all social contact. Does not initiate calls, messages, or visits. Tolerates his mother's visits but does not seek them. PRESENT — SEVERE.
Step 2: Differentiating Negative Symptoms from Depression
His mother's concern about depression is diagnostically important. Negative symptoms of Schizophrenia and depressive symptoms share surface features (withdrawal, anhedonia, psychomotor retardation) but differ in subjective experience and treatment response:
| Feature | Negative Symptoms (Schizophrenia) | Depression (MDD) | This Patient |
|---|---|---|---|
| Subjective mood | Neutral ('empty' or 'okay') | Sad, hopeless, worthless | Negative symptoms: mood is 'okay' |
| Anhedonia character | Absence of desire or motivation; no distress about it | Loss of previously experienced pleasure with distress | Negative symptoms: no distress about anhedonia |
| Sleep | Usually unremarkable | Often insomnia or hypersomnia | Unremarkable |
| Suicidality | Not typically driven by negative symptoms | Often present | Absent |
| Guilt/worthlessness | Absent | Prominent | Absent |
| Response to antidepressants | Poor | Good | N/A — not yet trialed |
| Onset pattern | Insidious, chronic | Episodic with identifiable onset | Insidious, progressive over years |
Differential Summary
The absence of subjective sadness, hopelessness, guilt, or suicidality, combined with the chronic/insidious onset and the absence of distress about the functional impairment, strongly favors primary negative symptoms of Schizophrenia over a comorbid Major Depressive Episode. MDD is not supported. The functional impairment is attributable to the deficit syndrome of Schizophrenia.
Diagnostic Formulation
Diagnostic Conclusion
Schizophrenia with Prominent Negative Symptoms (F20.5): Positive symptoms controlled on clozapine for 2 years. Five primary negative symptoms present at severe intensity (avolition, alogia, anhedonia, flat affect, asociality). MDD ruled out based on absence of subjective depressive symptoms. Medication-induced non-affective blunting should be assessed (benztropine anticholinergic effects, clozapine sedation), though the pattern predates current medication regimen. The deficit syndrome — persistent primary negative symptoms not secondary to depression, medication effects, or positive symptoms — is the most likely formulation.
Teaching Points
- Negative symptoms are the primary driver of functional disability in Schizophrenia. While antipsychotics effectively control positive symptoms (hallucinations, delusions), they have limited efficacy for negative symptoms. This treatment gap is one of the most significant unmet needs in schizophrenia management.
- The 'deficit syndrome' refers to primary, enduring negative symptoms that persist independently of positive symptoms, depression, medication effects, and environmental deprivation. Identifying the deficit syndrome has prognostic implications: it is associated with poorer long-term functional outcomes.
- Secondary negative symptoms must be ruled out before attributing them to the illness itself. Common secondary causes include: (1) medication side effects (antipsychotic-induced akinesia, sedation), (2) comorbid depression, (3) social deprivation or institutionalization, (4) active positive symptoms causing withdrawal.
- Anticholinergic medications (benztropine) can cause cognitive dulling and amotivation. Consider whether benztropine is still necessary after 2 years of stable treatment, as its discontinuation might improve negative symptom burden.
- Psychosocial interventions (supported employment, social skills training, cognitive remediation) are the most evidence-supported approaches for improving functional outcomes in patients with predominant negative symptoms, as pharmacological options remain limited.